KTTA
Pasithea Therapeutics Corp.
Industry
Biotechnology
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Loading...
Open
2.67
Mkt cap
3.3M
Volume
21K
High
2.78
P/E Ratio
-0.18
52-wk high
9.40
Low
2.58
Div yield
N/A
52-wk low
2.37

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.